TREATMENT-NAÏVE STUDIES
Dolutegravir-based regimens have been evaluated in the four Phase 3, active-control, noninferiority, treatment-naïve trials below
TREATMENT-EXPERIENCED STUDY
Dolutegravir-based regimens have been evaluated in the Phase 3, treatment-experienced, INSTI-naïve trial below
DLTWCNT210003
INSTI=integrase strand transfer inhibitor.